Black Diamond Therapeutics, Inc.
BDTX
$2.85
$0.020.71%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.12M | -8.50M | -10.56M | 56.54M | -15.99M |
| Total Depreciation and Amortization | 66.00K | 86.00K | 86.00K | 87.00K | 85.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.25M | 2.24M | 2.12M | 2.04M | 1.66M |
| Change in Net Operating Assets | -988.00K | -1.68M | -805.00K | -5.26M | -816.00K |
| Cash from Operations | -6.79M | -7.85M | -9.16M | 53.41M | -15.06M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 3.00K | 1.00K | 10.00K | 13.00K | 8.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.89M | 8.59M | -59.16M | 8.53M | 27.76M |
| Cash from Investing | -2.89M | 8.59M | -59.15M | 8.55M | 27.77M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 134.00K | -- | 32.00K | 291.00K |
| Repurchase of Common Stock | -196.00K | -- | -116.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -196.00K | 134.00K | -116.00K | 32.00K | 291.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.87M | 874.00K | -68.43M | 61.99M | 13.01M |